![Abhinav Jain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 127 885 $ in data 31/05/2026
Abhinav Jain is currently an Independent Director at Aytu Biopharma, Inc. since 2023, a Director at Xtant Medical Holdings, Inc. starting in 2025, an Independent Director at Eagle Pharmaceuticals, Inc. starting in 2025, and an Independent Director at Talphera, Inc. starting in 2024.
Formerly, Mr. Jain worked as an Associate at Angelo, Gordon & Co. LP.
from 2015 to 2017.
Education includes an undergraduate degree from Massachusetts Institute of Technology in 2012 and an MBA from The Wharton School of the University of Pennsylvania in 2019.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/11/2025 | 158.228 ( 0,11% ) | 73 101 $ | 31/05/2026 | |
AYTU BIOPHARMA, INC. 0,18% | 13/10/2025 | 19.500 ( 0,18% ) | 44 655 $ | 31/05/2026 |
TALPHERA, INC. 0,02% | 22/06/2026 | 12.412 ( 0,02% ) | 10 128 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AYTU BIOPHARMA, INC. | Direttore/Membro del Consiglio | 12/06/2023 |
| TALPHERA, INC. | Direttore/Membro del Consiglio | 22/01/2024 |
| XTANT MEDICAL HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/08/2025 |
| EAGLE PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 28/08/2025 |
| Società | Posizione | Fine |
|---|---|---|
Angelo, Gordon & Co. LP
 Angelo, Gordon & Co. LP Investment ManagersFinance TPG Angelo Gordon seeks alternative investment opportunities that will deliver consistent absolute returns for their clients. The firm manages capital across their Credit and Real Estate strategies, all of which employ a disciplined investment philosophy that combines fundamental in-depth research with a diversification strategy 20 designed to reduce downside risk. The research team is the cornerstone of all investment activities. | Corporate Officer/Principal | 01/01/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Angelo, Gordon & Co. LP
Angelo, Gordon & Co. LP Investment ManagersFinance TPG Angelo Gordon seeks alternative investment opportunities that will deliver consistent absolute returns for their clients. The firm manages capital across their Credit and Real Estate strategies, all of which employ a disciplined investment philosophy that combines fundamental in-depth research with a diversification strategy 20 designed to reduce downside risk. The research team is the cornerstone of all investment activities. | Finance |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Talphera, Inc.
 Talphera, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aytu Biopharma, Inc.
 Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Xtant Medical Holdings, Inc.
 Xtant Medical Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures and commercializes surgical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
